e-learning
resources
Stockholm 2007
Monday 17.09.2007
Interstitial lung disease: diagnostic and therapeutic novelties
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased pulmonary Wnt signaling in patients with sarcoidosis
B. Levänen, J. Grunewald, A. Eklund, J. Wahlström, M. Nord (Stockholm, Sweden)
Source:
Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Session:
Interstitial lung disease: diagnostic and therapeutic novelties
Session type:
Oral Presentation
Number:
1569
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Levänen, J. Grunewald, A. Eklund, J. Wahlström, M. Nord (Stockholm, Sweden). Increased pulmonary Wnt signaling in patients with sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 1569
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
Involvement of the Hedgehog signalling pathway in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Year: 2011
Hedgehog pathway activation is altered in COPD patients
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Dysregulation of the TGF-beta system in idiopathic pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 10s
Year: 2004
Decreased Wnt/β-catenin signaling in COPD: Possible involvement of Wnt antagonists
Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases
Year: 2012
Wnt signalling and parenchymal fibrosis
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019
Year: 2020
Four-and-a-half-LIM-domain (FHL)-2 acts as an enhancer of TGF-beta signaling in pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 296s
Year: 2007
Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis
Source: ERS Lung Science Conference 2016
Year: 2016
Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD)
Source: ERS Lung Science Conference 2017
Year: 2017
The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
TGF-β and BMP signal transduction pathways in pulmonary hypertension
Source: Annual Congress 2003 - Cell and molecular biology of pulmonary hypertension and COPD
Year: 2003
LSC Abstract – Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD
Source: Eur Respir J 2016; 47: 254-263
Year: 2016
Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Defective p53-mediated pro-apoptotic pathway in idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
Dysregulation of TGF-β/BMP signaling in a monocrotaline model of pulmonary hypertension
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006
Wnt and TGF-beta signaling in lung development
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept